BIS Research - Emerging Technology Market Intelligence

Liquid Biopsy Market is Projected to Register a CAGR of 14.45% by 2028

Oct 8, 2018 12:19:46 AM / by BIS Research posted in liquid biopsy industry, Global Liquid Biopsy End User Market, Healthcare & Medical, Global liquid biopsy market, Global Liquid Biopsy Market Share, Liquid biopsy market, liquid biopsy market report, Liquid Biopsy Market Size, liquid biopsy report

0 Comments

According to the International Agency for Research on Cancer around 14.1 million cases have been registered that are new and it is expected that this number can cross 21.7 million in future. All these cases are in turn increasing the economic burden of the people globally. The increase in the number of cancer cases, the increasing economic burden and most importantly the lack of sophisticated technology and diagnostics which can enable early detection of cancer are fuelling the research for novel technologies. Currently, to diagnose cancer the procedure conducted is known as tissue biopsy. The procedure is invasive in nature but does not support early diagnoses of cancer thus hindering the early treatment monitoring. This propelled the research on biomarkers present in the body fluids and led to the development of the non-invasive diagnostic procedure known as liquid biopsy. This technique involves the diagnosis of mutations occurring in the organs of the body with the screening of body fluids. According to a recent market intelligence report published by BIS Research titled, Global Liquid Biopsy MarketAnalysis and Forecast 2018 to 2028, the global market for it is expected to reach $2.94 billion by 2028 and with a CAGR of 14.45%.

Read More

    Subscribe to Email Updates

    Lists by Topic

    see all

    Have Questions? Schedule a Call